Thermo Fisher Scientific has opened a new cutting-edge facility in Runcorn, Cheshire.
Thermo Fisher Scientific has opened a new cutting-edge facility in Runcorn, Cheshire. The new facility represents a significant investment for the company and is a new designated Centre of Excellence for its Anatomical Pathology business.
The new facility is the company’s largest in the North of England and one of its biggest in the UK, with products and services to improve the detection and diagnosis of cancer and advance research for drug development. It is also a manufacturing centre for the company’s Chromatography Consumables business. These products are used in laboratories specializing in chromatography and mass spectrometry analysis. They enable detection, quantification and isolation of complex sample mixtures that are commonly encountered in pharmaceutical, environmental, biomedical, chemical, toxicology, forensics and food safety industries. The technology developed in Runcorn enables the company to meet demands for more specific and sensitive yet robust testing to support its customers.
In a statement, Giulio Cerroni, the company’s vice president of Anatomical Pathology commercial operations in Europe, the Middle East and Asia Pacific, said of the new facility: “We are delighted to announce the opening of the new facility in Runcorn, Cheshire. This is an important investment for the company, and we are already considering the next phase of development for the site. The new facility in Runcorn demonstrates the company’s commitment to better serving our customers by investing in the future of the business.”
The new facility was officially opened by Dr Yuh-geng Tsay, president, Specialty Diagnostics and Dr Roger Platt, chairman, Northwest Science Council.
For more information about the new Runcorn facility visit www.thermo.com
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.